Effects of Rebamipide on Gastrointestinal Symptoms in Patients with Type 2 Diabetes Mellitus

BACKGROUND: Gastrointestinal (GI) symptoms are common in patients with type 2 diabetes mellitus (T2DM). Rebamipide is an effective gastric cytoprotective agent, but there are few data on its usefulness in T2DM. The aim of this study is to evaluate the improvement of GI symptoms after rebamipide trea...

Descripción completa

Detalles Bibliográficos
Autores principales: Park, Sejeong, Park, So Young, Kim, Yu Jin, Hong, Soo Min, Chon, Suk, Oh, Seungjoon, Woo, Jeong-taek, Kim, Sung-Woon, Kim, Young Seol, Rhee, Sang Youl
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Korean Diabetes Association 2016
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4929228/
https://www.ncbi.nlm.nih.gov/pubmed/27098506
http://dx.doi.org/10.4093/dmj.2016.40.3.240

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4929228/
https://www.ncbi.nlm.nih.gov/pubmed/27098506
http://dx.doi.org/10.4093/dmj.2016.40.3.240

Ejemplares similares